BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND CDH11, OB, 1009, ENSG00000140937, CAD11, P55287
45 results:

  • 1. A personalized medicine approach identifies enasidenib as an efficient treatment for IDH2 mutant chondrosarcoma.
    Rey V; Tornín J; Alba-Linares JJ; Robledo C; Murillo D; Rodríguez A; Gallego B; Huergo C; Viera C; Braña A; Astudillo A; Heymann D; Szuhai K; Bovée JVMG; Fernández AF; Fraga MF; Alonso J; Rodríguez R
    EBioMedicine; 2024 Apr; 102():105090. PubMed ID: 38547578
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Therapeutic Hope on the Surface of Ewing Sarcoma.
    Bailey KM
    Clin Cancer Res; 2024 Mar; 30(5):934-936. PubMed ID: 38113033
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma.
    Mooney B; Negri GL; Shyp T; Delaidelli A; Zhang HF; Spencer Miko SE; Weiner AK; Radaoui AB; Shraim R; Lizardo MM; Hughes CS; Li A; El-Naggar AM; Rouleau M; Li W; Dimitrov DS; Kurmasheva RT; Houghton PJ; Diskin SJ; Maris JM; Morin GB; Sorensen PH
    Clin Cancer Res; 2024 Mar; 30(5):1022-1037. PubMed ID: 37812652
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Open Versus Core Needle Biopsy in Lower-Extremity Sarcoma: Current Practice Patterns and Patient Outcomes.
    Burke ZDC; Lazarides AL; Gundavda MK; Griffin AM; Tsoi KM; Ferguson PC; Wunder JS;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):57-64. PubMed ID: 37466581
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease.
    Lak NSM; Voormanns TL; Zappeij-Kannegieter L; van Zogchel LMJ; Fiocco M; van Noesel MM; Merks JHM; van der Schoot CE; Tytgat GAM; Stutterheim J
    Clin Cancer Res; 2021 Oct; 27(20):5576-5585. PubMed ID: 34285060
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of potential micro-messenger RNAs (miRNA-mRNA) interaction network of osteosarcoma.
    Xu K; Zhang P; Zhang J; Quan H; Wang J; Liang Y
    Bioengineered; 2021 Dec; 12(1):3275-3293. PubMed ID: 34252359
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Is Use of BMP-2 Associated with Tumor Growth and Osteoblastic Differentiation in Murine Models of Osteosarcoma?
    Kendal JK; Singla A; Affan A; Hildebrand K; Al-Ani A; Ungrin M; Mahoney DJ; Itani D; Jirik FR; Monument MJ
    Clin Orthop Relat Res; 2020 Dec; 478(12):2921-2933. PubMed ID: 33275394
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections.
    Sallah N; Miley W; Labo N; Carstensen T; Fatumo S; Gurdasani D; Pollard MO; Dilthey AT; Mentzer AJ; Marshall V; Cornejo Castro EM; Pomilla C; Young EH; Asiki G; Hibberd ML; Sandhu M; Kellam P; Newton R; Whitby D; Barroso I
    Nat Commun; 2020 Jul; 11(1):3849. PubMed ID: 32737300
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Cost-Neutral Optimization of Pazopanib Exposure by Splitting Intake Moments: A Prospective Pharmacokinetic Study in Cancer Patients.
    Groenland SL; van Eerden RAG; Verheijen RB; de Vries N; Thijssen B; Rosing H; Beijnen JH; Koolen SLW; Mathijssen RHJ; Huitema ADR; Steeghs N;
    Clin Pharmacokinet; 2020 Jul; 59(7):941-948. PubMed ID: 32020530
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Endocannabinoid/Endovanilloid System in Bone: From Osteoporosis to Osteosarcoma.
    Rossi F; Tortora C; Punzo F; Bellini G; Argenziano M; Di Paola A; Torella M; Perrotta S
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003519
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. SF2523 inhibits human chondrosarcoma cell growth in vitro and in vivo.
    Zhu JX; Xiao JR
    Biochem Biophys Res Commun; 2019 Apr; 511(3):559-565. PubMed ID: 30824188
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional Osteosarcoma.
    McHugh KE; Reith JD; Lucas DR; Emory CL; Mesko NW; Kilpatrick SE
    Am J Surg Pathol; 2019 May; 43(5):610-617. PubMed ID: 30807304
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The proto-oncogene function of Mdm2 in bone.
    Olivos DJ; Perrien DS; Hooker A; Cheng YH; Fuchs RK; Hong JM; Bruzzaniti A; Chun K; Eischen CM; Kacena MA; Mayo LD
    J Cell Biochem; 2018 Nov; 119(11):8830-8840. PubMed ID: 30011084
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Whole exome sequencing identifies PLEC, EXO5 and DNAH7 as novel susceptibility genes in testicular cancer.
    Paumard-Hernández B; Calvete O; Inglada Pérez L; Tejero H; Al-Shahrour F; Pita G; Barroso A; Carlos Triviño J; Urioste M; Valverde C; González Billalabeitia E; Quiroga V; Francisco Rodríguez Moreno J; Fernández Aramburo A; López C; Maroto P; Sastre J; José Juan Fita M; Duran I; Lorenzo-Lorenzo I; Iranzo P; García Del Muro X; Ros S; Zambrana F; María Autran A; Benítez J
    Int J Cancer; 2018 Oct; 143(8):1954-1962. PubMed ID: 29761480
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The anti-osteosarcoma cell activity by a mTORC1/2 dual inhibitor RES-529.
    Hu X; Wang Z; Chen M; Chen X; Liang W
    Biochem Biophys Res Commun; 2018 Mar; 497(2):499-505. PubMed ID: 29432734
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Diagnostic reliability of pretreatment biopsy in malignant nasoethmoidal tumors: A retrospective study of 77 cases.
    Schreiber A; Rampinelli V; Ferrari M; Mattavelli D; Farina D; Battocchio S; Nicolai P
    Laryngoscope; 2018 Aug; 128(8):1772-1777. PubMed ID: 29314070
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Preoperative Embolization and Complete Tumoral Resection of a Cervical Aggressive Epithelioid Osteoblastoma.
    Schur S; Camlioglu E; Jung S; Powell T; Gutman G; Golan J
    World Neurosurg; 2017 Oct; 106():1051.e1-1051.e4. PubMed ID: 28710051
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma.
    Matsuo K; Ross MS; Bush SH; Yunokawa M; Blake EA; Takano T; Ueda Y; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Takeuchi S; Nishimura M; Iwasaki K; Yanai S; Klobocista MM; Johnson MS; Machida H; Hasegawa K; Miyake TM; Nagano T; Pejovic T; Shahzad MM; Im DD; Omatsu K; Ueland FR; Kelley JL; Roman LD
    Gynecol Oncol; 2017 Feb; 144(2):329-335. PubMed ID: 27931750
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Teaming Up for Women's Health: The 2015 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting.
    Breitkopf DM; Demosthenes LD; Phelan ST
    Womens Health (Lond); 2015 Nov; 11(6):797-800. PubMed ID: 26618933
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Dual mTORC1/2 inhibition by INK-128 results in antitumor activity in preclinical models of osteosarcoma.
    Jiang H; Zeng Z
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):255-61. PubMed ID: 26514724
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.